BMS ‘Increasingly Confident’ It Can Handle The Impact Of Medicare Pricing For Eliquis
Pharma To Announce IRA-Mandated Final Price Soon
Bristol’s CEO offered assurances about Medicare negotiations under the IRA as the company delivered better-than-expected second quarter results across new and legacy products.
